Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
SJ Wood, TM Kuzel, SH Shafikhani - Cells, 2023 - mdpi.com
Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen which
causes many severe acute and chronic infections with high morbidity, and mortality rates as …
causes many severe acute and chronic infections with high morbidity, and mortality rates as …
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients
M Mikulska, C Viscoli, C Orasch, DM Livermore… - Journal of Infection, 2014 - Elsevier
Objectives A knowledge of current epidemiology and resistance patterns is crucial to the
choice of empirical treatment for bacteraemias in haematology and cancer patients. Methods …
choice of empirical treatment for bacteraemias in haematology and cancer patients. Methods …
Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study
C Van Delden, S Stampf, HH Hirsch… - Clinical infectious …, 2020 - academic.oup.com
Background The burden and timeline of posttransplant infections are not comprehensively
documented in the current era of immunosuppression and prophylaxis. Methods In this …
documented in the current era of immunosuppression and prophylaxis. Methods In this …
Invasive fungal infections in solid organ transplant recipients
Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …
The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection …
Background Invasive candidiasis (IC) is a common cause of mortality in solid organ
transplant recipients (OTR s), but knowledge of epidemiology in this population is limited …
transplant recipients (OTR s), but knowledge of epidemiology in this population is limited …
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
JM Aguado, JT Silva, M Fernández-Ruiz… - Transplantation …, 2018 - Elsevier
Solid organ transplant (SOT) recipients are especially at risk of developing infections by
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …
Multidrug‐resistant Gram‐negative bacterial infections in solid organ transplant recipients—Guidelines from the American Society of Transplantation Infectious …
SM Pouch, G Patel… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …
American Society of Transplantation review the diagnosis, prevention, and management of …
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients
M Bodro, N Sabé, F Tubau, L Lladó, C Baliellas… - …, 2013 - journals.lww.com
Background Although infections due to the six ESKAPE pathogens have recently been
identified as a serious emerging problem, information regarding bacteremia caused by …
identified as a serious emerging problem, information regarding bacteremia caused by …
Multidrug‐resistant bacteria in solid organ transplant recipients
Bacteria are the leading cause of infections after solid organ transplantation. In recent years,
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …
[HTML][HTML] Infections in liver transplant recipients
FA Romero, RR Razonable - World journal of hepatology, 2011 - ncbi.nlm.nih.gov
Liver transplantation is a standard life-saving procedure for the treatment of many end-stage
liver diseases. The success of this procedure may be limited by infectious complications. In …
liver diseases. The success of this procedure may be limited by infectious complications. In …